International Laboratories, LLC is recalling approximately 218,772 bottles of Clopidogrel tablets (75 mg), a medication used to prevent blood clots. The recall was issued because some bottles labeled as Clopidogrel actually contain Simvastatin (10 mg), which is a cholesterol-lowering medication. Consumers who unknowingly take Simvastatin instead of their prescribed Clopidogrel will not receive the blood-thinning benefits they require and may experience unintended side effects. You should contact your healthcare provider or pharmacist immediately to obtain the correct medication and return any unused bottles to the place of purchase for a refund.
Patients taking the wrong medication will miss their prescribed blood-thinning treatment, which increases the risk of serious cardiovascular events. Additionally, taking Simvastatin unintentionally may cause drug interactions or adverse side effects associated with cholesterol medication.
Healthcare guidance and product refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.